A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

The increasing incidence of sexually transmitted bacterial infections (STIs) is a major public health problem worldwide.

Human immunodeficiency virus (HIV) is a condition that attacks a person's immune system. The immune system helps identify and destroy pathogens that cause infection and illness in the body. The risk ...

A health worker takes blood samples of people who want to undertake voluntary HIV testing at the University of the Philippines Manila. Jonathan Cellona, ABS-CBN News/FileMANILA — The Philippines ...

Ireland based pharmaceutical company Gilead Sciences has said it will grant licences to six generic manufacturers to produce low cost lenacapavir, which has shown unprecedented efficacy at preventing ...

If you ever test positive for HIV, you will need to start treatment for HIV. Because Apretude is a long-acting injection, it can remain in your body for up to 12 months or longer after the last dose.